Monitor the Florida court docket for responsive pleadings or a hearing date. A ruling quieting title in the company would be a significant positive catalyst, reducing share count by ~31% without any cash outlay. An adverse ruling or settlement with claimants would leave the overhang unresolved and could lead to further litigation.
Price Chart
Executive Summary
Adia Med, Inc. filed a declaratory judgment action in Florida state court seeking to quiet title to 29,059,792 shares (30.78% of outstanding common stock, valued at $3,487,175.04 as of August 13, 2026) that the company alleges were never validly issued or paid for. The complaint names 13 purported holders and claims the transfer agent has no record of original issuance. The outcome is uncertain — a favorable ruling could reduce outstanding shares by up to 30.78%, while an adverse result would leave the shares outstanding in the claimants' names.
Key Facts
- Adia Med filed a Verified Complaint for Declaratory Judgement on September 28, 2026 in Seminole County, Florida (Case No. 2026CA002155).
- The action seeks to quiet title to 29,059,792 shares of non-preferred common stock, representing 30.78% of issued and outstanding shares.
- The subject shares had a market value of $3,487,175.04 based on the closing price on August 13, 2026.
- The complaint alleges the shares were never validly issued and that claimants never paid for them; the transfer agent has no record of original issuance.
- 13 purported holders are named as defendants, including individuals and entities based in California, Hong Kong, London, and Washington, D.C.
- A favorable judgment could reduce outstanding shares by up to 29,059,792 shares; an adverse result would leave the shares outstanding.
- No responsive pleading has been filed and no hearing has been set as of the report date.
- The company's common stock trades on the OTC Markets Venture Market under ticker ADIA.
Financial Impact
Up to 30.78% reduction in outstanding shares (29,059,792 shares valued at $3,487,175.04) if the company prevails; no financial impact if the company loses.
Risk Factors
- Claimants may appear and contest jurisdiction, venue, or assert the shares were validly issued or transferred.
- Adverse result leaves the subject shares remain outstanding in the names of the claimants.
- Litigation costs and uncertainty of outcome; no timeline for resolution provided.
- Potential for related proceedings or counterclaims.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001683168-26-007624 |
| Document: adia_ex9901.htm | 0001683168-26-007624 |
| Document: 0001683168-26-007624-index-headers.html | 0001683168-26-007624 |
| Document: 0001683168-26-007624-index.html | 0001683168-26-007624 |
| Document: 0001683168-26-007624.txt | 0001683168-26-007624 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 8-K | $0.1300 | awaiting T+20 | — | $0.1250 (−3.85%) |
Oct 13, 2026 13d ago | 8-K | $0.1470 | awaiting T+20 | — | $0.1250 (−14.97%) |
Oct 5, 2026 21d ago | 8-K | $0.1480 | awaiting T+20 | — | $0.1250 (−15.54%) |
Oct 5, 2026 21d ago | 8-K | $0.1480 | awaiting T+20 | — | $0.1250 (−15.54%) |
Aug 24, 2026 9w ago | 8-K | $0.1170 $0.1450 | ▲ +23.93% | ▲ +23.92% | $0.1250 (+6.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers